UB
VKTX icon

UMB Bank’s Viking Therapeutics VKTX Stock Holding History

UMB Bank’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.8K Buy
481
+134
+39% +$4.33K ﹤0.01% 1695
2026
Q1 		$11.3K Buy
347
+32
+10% +$1.03K ﹤0.01% 1813
2025
Q4 		$11.1K Sell
315
-343
-52% -$12.2K ﹤0.01% 1789
2025
Q3 		$17.3K Buy
658
+456
+226% +$13.6K ﹤0.01% 1491
2025
Q2 		$5.35K Sell
202
-3
-1% -$79 ﹤0.01% 1807
2025
Q1 		$4.95K Buy
205
+3
+1% +$95 ﹤0.01% 1758
2024
Q4 		$8.13K Hold
202
– – ﹤0.01% 1538
2024
Q3 		$12.8K Buy
+202
New +$11.9K ﹤0.01% 1394

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

UMB Bank's VKTX Position: Q2 2026 in Review

UMB Bank increased its Viking Therapeutics (VKTX) stake by 39% in Q2 2026, buying an estimated $4.33K and bringing the position to 481 shares worth $18.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1695.

UMB Bank first reported a position in VKTX in Q3 2024 and has held it in 8 quarters since. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • UMB Bank held 481 shares of Viking Therapeutics worth $18.8K as of Q2 2026.
  • UMB Bank bought 134 Viking Therapeutics shares in Q2 2026, an estimated $4.33K.
  • Viking Therapeutics made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1695 holding.
  • UMB Bank first reported a position in Viking Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.